SEC 13F Intelligence

Falcon Point Capital, LLC / LGND

Falcon Point Capital, LLC’s Ligand Pharmaceuticals Inc Position

Does Falcon Point Capital, LLC own Ligand Pharmaceuticals Inc (LGND)? Not currently — the last reported position was 2.9K shares worth $321,000 in Q2 2020; the fund’s latest 13F (Q4 2020) no longer reports it.

Position Value
$321,000
Q2 2020
Shares
2.9K
% of Portfolio
+1.57%
Quarters Held
6
position exited

Position History LGND

Reported value by quarter
Q1 ’19: $4MQ1 ’19Q2 ’19: $4MQ2 ’19Q3 ’19: $4MQ3 ’19Q4 ’19: $846,000Q4 ’19Q1 ’20: $504,000Q1 ’20Q2 ’20: $321,000Q2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20202.9K$321,000+1.57%
Q1 20206.9K$504,000+1.09%
Q4 20198.1K$846,000+1.08%
Q3 201932.8K$4M+1.96%
Q2 201931.1K$4M+1.91%
Q1 201930.5K$4M+2.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Falcon Point Capital, LLC’s full portfolio or all institutional holders of LGND.